On which day after starting progesterone (a hormone) supplementation is a blastocyst (an embryo that has developed for 5-6 days) transfer typically done in a standard in vitro fertilization (IVF) protocol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blastocyst Transfer Timing After Progesterone Initiation

Blastocyst transfer should be performed on day 5 or day 6 after starting progesterone supplementation, with the optimal timing being 117-120 hours (approximately 5 days) after the first progesterone dose. 1

Standard Protocol for Frozen Blastocyst Transfer

The timing of blastocyst transfer is calculated from the first progesterone dose and follows a precise schedule 1:

  • Day 5 blastocysts: Transfer on day 5 of progesterone (120 hours after progesterone initiation) 2, 3
  • Day 6 blastocysts: Transfer on day 6 or day 7 of progesterone, with day 7 showing superior outcomes 4, 3

Evidence-Based Timing Recommendations

For Day 5 Blastocysts

Transfer on the 5th day of progesterone administration yields optimal outcomes. 2, 3 Recent evidence demonstrates that day 5 blastocysts transferred on day 5 versus day 6 of progesterone show comparable pregnancy outcomes, though the 5-day protocol is standard 3.

For Day 6 Blastocysts

Transfer on the 7th day of progesterone is strongly preferred over the 6th day for day 6 blastocysts. 4, 3 This recommendation is based on:

  • Significantly higher live birth rates (44.8% vs 36.4%) when transferred on day 7 versus day 6 of progesterone 3
  • Lower pregnancy loss rates (15.4% vs 25.2%) with the 7-day protocol 3
  • Markedly reduced miscarriage rates (21.4% vs 50.0%) when day 6 blastocysts are transferred on day 7 versus day 6 of progesterone 4

Critical Pre-Transfer Requirements

Before initiating progesterone, the following must be confirmed 1, 5:

  • Estrogen priming duration: Continue estradiol (Progynova 6mg daily) for 12-14 days minimum before starting progesterone 1, 5
  • Endometrial thickness: ≥7-8mm with trilaminar pattern on ultrasound 1, 5
  • Adequate endometrial preparation: Confirmed via transvaginal ultrasound on day 12-14 of the cycle 5

Common Pitfalls to Avoid

Never start progesterone on a fixed cycle day without confirming adequate endometrial preparation. 1 The most critical error is initiating progesterone prematurely (e.g., on cycle day 9) without ensuring 12-14 days of estrogen exposure, which risks poor implantation outcomes 1.

Do not transfer day 6 blastocysts on day 6 of progesterone. 4, 3 This timing is associated with a 50% miscarriage rate compared to 21.4% when transferred on day 7 of progesterone 4.

The Implantation Window

The window for successful embryo transfer depends critically on progesterone duration 6:

  • Opens approximately 48 hours (2 days) after starting progesterone 6
  • Remains open for approximately 4 days 6
  • Optimal transfer occurs on days 18-19 of an artificial cycle (corresponding to 4-5 days of progesterone for cleavage-stage embryos) 6

For blastocysts specifically, this translates to day 5-6 of progesterone for day 5 blastocysts and day 6-7 for day 6 blastocysts, with day 7 being superior for the latter 4, 3.

Progesterone Administration Protocol

Once endometrial preparation is confirmed 1, 5:

  • Initiate progesterone: 800mg vaginal daily (or 200mg three times daily micronized vaginal progesterone) 5, 4
  • Calculate transfer timing: Precisely 117-120 hours after first progesterone dose for day 5 blastocysts 1
  • Adjust for embryo age: Add one day of progesterone exposure for day 6 blastocysts 4, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.